Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-27
1995-10-17
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483147, A61K 31415, C07D40310
Patent
active
054591562
ABSTRACT:
Imidazolyl-substituted phenylacetic acid prolinamides are prepared by reacting corresponding imidazolyl-substituted phenylacetic acids with prolines. The imidazolyl-substituted phenylacetic acid prolinamides can be used as active compounds in medicaments, preferably for the treatment of hypertension and atherosclerosis.
REFERENCES:
patent: 5128355 (1992-07-01), Carini et al.
patent: 5138069 (1992-08-01), Carini et al.
patent: 5153197 (1992-10-01), Carini et al.
patent: 5155118 (1992-10-01), Carini et al.
J. Med. Chem., 1990, vol. 33, pp. 1312-1329; "The Discovery of Potent Non-peptide Angiotensin II Receptor . . . ", J. V. Duncia et al.
The Journal of Cell Biology, vol. 50, 1971, pp. 172-186.
Beuck Martin
Dressel Jurgen
Fey Peter
Hanko Rudolf H.
Hubsch Walter
Bayer Aktiengesellschaft
Morris Patricia L.
LandOfFree
Imidazolyl-substituted phenylacetic acid prolinamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl-substituted phenylacetic acid prolinamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl-substituted phenylacetic acid prolinamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597618